Showing 1691-1700 of 6936 results for "".
What's New in Topical Treatment for Plaque Psoriasis?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-in-topical-treatment-for-plaque-psoriasis/20235/Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, discusses what’s new in topical treatment of plaque psoriasis and the importance of an “elegant vehicle” for patients to use in their care regimens.Dermatology Innovations
https://practicaldermatology.com/topics/psoriasis/dermatology-innovations/20044/From topical therapies to JAK inhibitors, there are many new drugs available to treat a wide variety of dermatologic conditions. Neal Bhatia, MD reviews what's new for atopic dermatitis, alopecia areata, scabies, lice, onychomycosis, and more. Plus, he discusses the importance of new delivery systemAtopic Dermatitis in the Spotlight: Uncovering the Burden Beneath the Skin?
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-in-the-spotlight-uncovering-the-burden-beneath-the-skin/20030/Highlighting the common symptoms experienced by patients and their perceived burden (including itch, lesions, pain and sleep disturbance), the impact of symptoms and particularly sleep disturbance on quality of life, activity, and mental health and the different atopic dermatitis phenotypes and relaAll Dressed Up: Optimal Wound Control to Reduce Scars
https://practicaldermatology.com/topics/skin-cancer-photoprotection/all-dressed-up-optimal-wound-control-to-reduce-scars/20022/Performing more than 25 million surgical procedures each year, dermatologists have the potential to create innumerable scars. Mara Weinstein Velez, MD talks about the best dressings to use to reduce the risk of scars and offers a look at laser-assisted drug delivery to address existing scars.DermWireTV: NPF on Boosters; Galderma Raises Awareness, World Eczema Day, and more
https://practicaldermatology.com/topics/psoriasis/dermwiretv-npf-on-boosters-galderma-raises-awareness-world-eczema-day-and-more/20002/Launched on World Eczema Day, the Global Patient Initiative to Improve Eczema Care represents 11 patient organizations from eight countries. The initiative is supported with funding from LEO Pharma. GlobalSkin marked World Eczema Day by calling on health care professionals, health policy decision maConversations in Acne, Part 3
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-3/19877/What do we know about the anti-inflammatory effects of antibiotics? How can we reduce risks for creating resistance or affecting the gut microbiome? Host Neal Bhatia, MD leads a conversation on these topics and more with Hilary Baldwin, MD and James Q. Del Rosso, DO.Is There Evidence that Topical Formulations Can Support the Microbiome?
https://practicaldermatology.com/topics/atopic-dermatitis/is-there-evidence-that-topical-formulations-can-support-the-microbiome/19826/There is a growing body of research on the importance of the microbiome as well as the potential to support a healthy microbiome through topical product selection, Dr. Friedman says.Actinic Keratosis: Therapy Overview
https://practicaldermatology.com/topics/skin-cancer-photoprotection/actinic-keratosis-therapy-overview/19732/Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be sModifying Masseters and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/modifying-masseters-and-more/19698/Artful use of neurotoxin in the masseters and parotid glands can help thin the appearance of the face. Chytra Anand, MD discusses her approach and talks about treatments used in her home country of India.Psoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic fr